• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Epidemiology of Acute Liver Failure.急性肝衰竭的流行病学。
Dtsch Arztebl Int. 2020 Jan 24;117(4):43-50. doi: 10.3238/arztebl.2020.0043.
2
Pediatric acute liver failure in Brazil: Is living donor liver transplantation the best choice for treatment?巴西的儿童急性肝衰竭:活体供肝肝移植是最佳治疗选择吗?
Liver Transpl. 2016 Jul;22(7):1006-13. doi: 10.1002/lt.24435.
3
Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.日本活体供肝肝移植治疗急性肝衰竭的结局:一项全国性调查结果。
Liver Transpl. 2012 Sep;18(9):1069-77. doi: 10.1002/lt.23469.
4
Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015.日本自身免疫性急性肝衰竭患者肝移植的感染性并发症和时机:基于 2010 年至 2015 年全国性调查的亚分析
J Gastroenterol. 2020 Sep;55(9):888-898. doi: 10.1007/s00535-020-01699-3. Epub 2020 Jun 17.
5
Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.美国等待肝移植的急性肝衰竭患者的预后决定因素。
Liver Transpl. 2016 Apr;22(4):505-15. doi: 10.1002/lt.24347.
6
Acute liver failure in Lithuania.立陶宛的急性肝衰竭
Medicina (Kaunas). 2008;44(7):536-40.
7
Living Donor Liver Transplantation in Acute Liver Failure Patients with Grade IV Encephalopathy: Is Deep Hepatic Coma Still an Absolute Contraindication? A Successful Single-Center Experience.急性肝功能衰竭伴IV级肝性脑病患者的活体肝移植:深度肝昏迷仍然是绝对禁忌证吗?单中心成功经验
Ann Transplant. 2018 Mar 13;23:176-181. doi: 10.12659/AOT.907274.
8
Living Donor Liver Transplantation for Acute Liver Failure : Comparing Guidelines on the Prediction of Liver Transplantation.活体肝移植治疗急性肝衰竭:肝移植预测指南比较
Acta Med Okayama. 2017 Oct;71(5):381-390. doi: 10.18926/AMO/55435.
9
MELD score as a prognostic model for listing acute liver failure patients for liver transplantation.终末期肝病模型(MELD)评分作为急性肝衰竭患者肝移植列入标准的预后模型。
Transplant Proc. 2006 Sep;38(7):2097-8. doi: 10.1016/j.transproceed.2006.06.004.
10
Outcome comparison of liver transplantation for hepatitis A-related versus hepatitis B-related acute liver failure in adult recipients.成年受者中甲型肝炎相关与乙型肝炎相关急性肝衰竭肝移植的结局比较
Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13140. Epub 2017 Dec 18.

引用本文的文献

1
Expanding the boundaries of kidney replacement therapy in patients with liver failure.拓展肝衰竭患者肾脏替代治疗的边界。
World J Crit Care Med. 2025 Sep 9;14(3):105235. doi: 10.5492/wjccm.v14.i3.105235.
2
Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis.病因明确而非不明的急性肝衰竭有助于治疗并可能避免肝移植:一项批判性分析。
J Clin Transl Hepatol. 2025 Aug 28;13(8):693-700. doi: 10.14218/JCTH.2025.00203. Epub 2025 Aug 7.
3
Keap1 Deletion Rescues Cell Death Associated With Gpx4 Loss in Hepatocytes During Acute Liver Injury.在急性肝损伤期间,Keap1缺失可挽救与肝细胞中Gpx4缺失相关的细胞死亡。
Liver Int. 2025 Sep;45(9):e70210. doi: 10.1111/liv.70210.
4
Acute liver failure in patients admitted to the intensive care unit-a Viennese retrospective single-center analysis.重症监护病房收治患者的急性肝衰竭——一项维也纳单中心回顾性分析
Wien Klin Wochenschr. 2025 May 26. doi: 10.1007/s00508-025-02539-1.
5
From fructose to the future: liver disease biomarkers and their prognostic value in acute liver failure.从果糖到未来:急性肝衰竭中的肝脏疾病生物标志物及其预后价值
Crit Rev Clin Lab Sci. 2025 Aug;62(5):386-403. doi: 10.1080/10408363.2025.2481081. Epub 2025 Mar 27.
6
Acute liver failure and liver transplantation.急性肝衰竭与肝移植
Indian J Gastroenterol. 2025 Feb 18. doi: 10.1007/s12664-024-01708-w.
7
Predictive value of systemic immune-inflammatory biomarkers for drug-induced liver injury in hepatitis B virus surface antigen positive tuberculosis patients: A retrospective observational study.系统免疫炎症生物标志物对乙肝表面抗原阳性结核病患者药物性肝损伤的预测价值:一项回顾性观察研究。
Medicine (Baltimore). 2024 Nov 8;103(45):e40349. doi: 10.1097/MD.0000000000040349.
8
Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver failure.评估新型谷胱甘肽和初榨椰子油纳米颗粒制剂在四氯化碳诱导肝衰竭实验模型中的治疗潜力。
BMC Pharmacol Toxicol. 2024 Oct 8;25(1):74. doi: 10.1186/s40360-024-00795-x.
9
No Significant Beneficial Effects of Intravenous N-Acetylcysteine on Patient Outcome in Non-Paracetamol Acute Liver Failure: A Meta-Analysis of Randomized Controlled Trials.静脉注射N-乙酰半胱氨酸对非对乙酰氨基酚急性肝衰竭患者预后无显著有益影响:一项随机对照试验的荟萃分析
Biomedicines. 2024 Jul 1;12(7):1462. doi: 10.3390/biomedicines12071462.
10
[Liver transplantation in acute and acute-on-chronic liver failure].[急性和慢加急性肝衰竭中的肝移植]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):484-492. doi: 10.1007/s00063-024-01158-4. Epub 2024 Jul 23.

本文引用的文献

1
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.中国内地药物性肝损伤的发生率及病因学。
Gastroenterology. 2019 Jun;156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002. Epub 2019 Feb 8.
2
The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study.泰国急性肝衰竭的发病率、病因、结局及死亡预测因素:一项基于人群的研究。
BMC Gastroenterol. 2019 Jan 28;19(1):18. doi: 10.1186/s12876-019-0935-y.
3
Characteristics and outcomes of patients with acute liver failure admitted to Australian and New Zealand intensive care units.澳大利亚和新西兰重症监护病房收治的急性肝衰竭患者的特征和结局。
Intern Med J. 2019 Jul;49(7):874-885. doi: 10.1111/imj.14167.
4
Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality.不明原因急性肝衰竭:专家委员会建立因果关系的全面系统方法。
Am J Gastroenterol. 2018 Sep;113(9):1319. doi: 10.1038/s41395-018-0160-2. Epub 2018 Jun 27.
5
Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.日本全国范围内的急性肝衰竭和迟发性肝衰竭调查。
J Gastroenterol. 2018 Jun;53(6):752-769. doi: 10.1007/s00535-017-1394-2. Epub 2017 Oct 13.
6
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.欧洲肝脏研究学会急性(暴发性)肝衰竭管理临床实践指南。
J Hepatol. 2017 May;66(5):1047-1081. doi: 10.1016/j.jhep.2016.12.003.
7
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.西方国家肝癌发病率、治疗方法和生存率的地域差异。
J Hepatol. 2017 Mar;66(3):537-544. doi: 10.1016/j.jhep.2016.10.015. Epub 2016 Oct 20.
8
Liver Failure due to Acute Viral Hepatitis (A-E).急性病毒性肝炎(A - E型)所致肝衰竭
Visc Med. 2016 Apr;32(2):80-5. doi: 10.1159/000444915. Epub 2016 Apr 7.
9
Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure.预测急性肝衰竭患者无移植生存的模型的开发。
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1199-1206.e2. doi: 10.1016/j.cgh.2016.03.046. Epub 2016 Apr 13.
10
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.1998年至2013年成人急性肝衰竭的预后:一项观察性队列研究
Ann Intern Med. 2016 Jun 7;164(11):724-32. doi: 10.7326/M15-2211. Epub 2016 Apr 5.

急性肝衰竭的流行病学。

The Epidemiology of Acute Liver Failure.

机构信息

Department of Medicine 1, Frankfurt University Hospital, Frankfurt am Main; WIdO - AOK Research Institute, Berlin; Department of General and Visceral Surgery, Frankfurt University Hospital, Frankfurt am Main.

出版信息

Dtsch Arztebl Int. 2020 Jan 24;117(4):43-50. doi: 10.3238/arztebl.2020.0043.

DOI:10.3238/arztebl.2020.0043
PMID:32036852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036472/
Abstract

BACKGROUND

Acute liver failure (ALF) is a life-threatening event associated with high mortality. Currently, only estimates are available for its incidence. The aim of the study was to assess the incidence of ALF in Germany, using the accounting data of the largest statutory health insurance company, which represents 26.5 million people.

METHODS

The analysis included patients insured from 1 January 2014 to 31 December 2018. Coding with the International Statistical Classification of Diseases and Related Health Problems and the German operation and procedure codes were used to identify the patients, whose age, sex, liver transplantations (LT), and fatal outcomes were then recorded and extrapolated to the total population. As a validity check, the extrapolated LT results were compared with the LT that were actually performed.

RESULTS

The calculated incidence of ALF was 1.13/100 000 person-years, representing 4652 cases. Women were more often affected (52% versus 48%, p < 0.001). The overall rate of mortality within 3 months was 47%. A total of 203 LT were recorded in 176 patients. Men received 41% of the LT, women 59% (p < 0.137). The 1-year overall mortality rate after LT was 20%. The 203 calculated transplantations corresponded to 228 actually performed transplantations.

CONCLUSION

The incidence of ALF was higher than previously estimated for Germany, with only a very low rate of LT despite high mortality. When extrapolating ny, it must be borne in mind that those insured by the company concerned do not represent a valid sample.

摘要

背景

急性肝衰竭 (ALF) 是一种危及生命的事件,死亡率很高。目前,仅对其发病率进行了估计。本研究的目的是使用最大的法定健康保险公司的会计数据评估德国的 ALF 发病率,该公司代表 2650 万人。

方法

分析包括 2014 年 1 月 1 日至 2018 年 12 月 31 日期间投保的患者。使用国际疾病分类和相关健康问题的统计分类和德国手术和程序代码对患者进行编码,记录其年龄、性别、肝移植 (LT) 和死亡结局,并外推至总人口。作为有效性检查,将外推的 LT 结果与实际进行的 LT 进行比较。

结果

计算的 ALF 发病率为 1.13/100000 人年,代表 4652 例。女性更常受到影响 (52%比 48%,p < 0.001)。3 个月内的总死亡率为 47%。共记录了 176 名患者的 203 例 LT。男性接受了 41%的 LT,女性接受了 59% (p < 0.137)。LT 后 1 年的总死亡率为 20%。计算的 203 例移植与实际进行的 228 例移植相对应。

结论

德国的 ALF 发病率高于此前估计,尽管死亡率很高,但 LT 率却非常低。在进行外推时,必须记住,有关公司承保的人并不代表有效的样本。